Suk-Jae Chung

1.5k citations
31 papers · 1.2k indexed · h-index 15
Topics
Drug Transport and Resistance Mechanisms (8 papers)Advanced Drug Delivery Systems (6 papers)Advancements in Transdermal Drug Delivery (5 papers)

In The Last Decade

Suk-Jae Chung

28 papers receiving 1.1k citations

Peers

Suk-Jae Chung
Comparison fields: 5 of 103
  • Pharmaceutical Science 494
  • Molecular Biology 297
  • Physiology 164
  • Biomaterials 154
  • Oncology 150
Replace Masawo Kakemi with:
Masawo Kakemi Japan
Galit Levin Israel
Takayoshi Yoshikawa Japan
Yu‐Li Lo Taiwan
Toshikiro Kimura Japan
Nitin K. Swarnakar India
Imran Shair Mohammad China
Zerrin Sezgin Bayındır Türkiye
Myung Joo Kang South Korea
Suk-Jae Chung relative to Masawo Kakemi Japan Masawo Kakemi's profile →
Citations per field
00.5×1.5×2.4×
Masawo Kakemi · 1×
Citations per year

Countries citing papers authored by Suk-Jae Chung

Since Specialization
Citations

This map shows the geographic impact of Suk-Jae Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suk-Jae Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suk-Jae Chung more than expected).

Fields of papers citing papers by Suk-Jae Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suk-Jae Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suk-Jae Chung. The network helps show where Suk-Jae Chung may publish in the future.

Co-authorship network of co-authors of Suk-Jae Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Suk-Jae Chung. A scholar is included among the top collaborators of Suk-Jae Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suk-Jae Chung. Suk-Jae Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 98
3 5
4 17
5 66
6 28
7 14
8 280
9 9
10 4
11 3
12 77
13 111
14
Statatistical Analysis of Three Sequence-Three Periods Bioequivalence Study : Application to Bioequivalence Test of Ondansetron Formulations
0
15
Development of $K-BEtest^{\circledR}$, a Computer Program for the Analysis of Bioequivalence
2
16 24
17 7
18 15
19 9
20
Effect of Sodium Taurodeoxycholate on Biliary Excretion of Amaranth as an Anionic Model Drug in Rats
0

About Suk-Jae Chung

Suk-Jae Chung is a scholar working on Pharmaceutical Science, Physiology and Oncology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Advanced Drug Delivery Systems (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). The work is most often cited by research in Pharmaceutical Science (494 citations), Dermatology (130 citations) and Biomaterials (154 citations). Suk-Jae Chung has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Chang‐Koo Shim, Dae‐Duk Kim, Saeho Chong, Ho‐Leung Fung, Prabagar Balakrishnan, Chung Kil Song, Hyun‐Jong Cho, Min-Hwa Lee, Shengjie Bian and Hongxia Lin. Their work appears in journals such as Biomaterials, Journal of Controlled Release and The American Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026